Dataset Information

Integrating Air Quality and Public Health Benefits in U.S. Decarbonization Strategies.

ABSTRACT: Research on air quality and human health "co-benefits" from climate mitigation strategies represents a growing area of policy-relevant scholarship. Compared to other aspects of climate and energy policy evaluation, however, there are still relatively few of these co-benefits analyses. This sparsity reflects a historical disconnect between research quantifying energy and climate, and research dealing with air quality and health. The air quality co-benefits of climate, clean energy, and transportation electrification policies are typically assessed with models spanning social, physical, chemical, and biological systems. This review article summarizes studies to date and presents methods used for these interdisciplinary analyses. Studies in the peer-reviewed literature (n = 26) have evaluated carbon pricing, renewable portfolio standards, energy efficiency, renewable energy deployment, and clean transportation. A number of major findings have emerged from these studies: [1] decarbonization strategies can reduce air pollution disproportionally on the most polluted days; [2] renewable energy deployment and climate policies offer the highest health and economic benefits in regions with greater reliance on coal generation; [3] monetized air quality health co-benefits can offset costs of climate policy implementation; [4] monetized co-benefits typically exceed the levelized cost of electricity (LCOE) of renewable energies; [5] Electric vehicle (EV) adoption generally improves air quality on peak pollution days, but can result in ozone dis-benefits in urban centers due to the titration of ozone with nitrogen oxides. Drawing from these published studies, we review the state of knowledge on climate co-benefits to air quality and health, identifying opportunities for policy action and further research.

SUBMITTER: Gallagher CL

PROVIDER: S-EPMC7717953 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Integrating Air Quality and Public Health Benefits in U.S. Decarbonization Strategies.

Gallagher Ciaran L CL Holloway Tracey T

Frontiers in public health 20201119

Research on air quality and human health "co-benefits" from climate mitigation strategies represents a growing area of policy-relevant scholarship. Compared to other aspects of climate and energy policy evaluation, however, there are still relatively few of these co-benefits analyses. This sparsity reflects a historical disconnect between research quantifying energy and climate, and research dealing with air quality and health. The air quality co-benefits of climate, clean energy, and transporta ...[more]

PMID: 33330312

Similar Datasets

Project description:Policies to mitigate greenhouse gas (GHG) emissions will not only slow climate change, but can also have ancillary benefits of improved air quality. Here we examine the co-benefits of both global and regional GHG mitigation on U.S. air quality in 2050 at fine resolution, using dynamical downscaling methods, building on a previous global co-benefits study (West et al., 2013). The co-benefits for U.S. air quality are quantified via two mechanisms: through reductions in co-emitted air pollutants from the same sources, and by slowing climate change and its influence on air quality, following West et al. (2013). Additionally, we separate the total co-benefits into contributions from domestic GHG mitigation versus mitigation in foreign countries. We use the WRF model to dynamically downscale future global climate to the regional scale, the SMOKE program to directly process global anthropogenic emissions into the regional domain, and we provide dynamical boundary conditions from global simulations to the regional CMAQ model. The total co-benefits of global GHG mitigation from the RCP4.5 scenario compared with its reference are estimated to be higher in the eastern U.S. (ranging from 0.6-1.0 ?g m-3) than the west (0-0.4 ?g m-3) for PM2.5, with an average of 0.47 ?g m-3 over U.S.; for O3, the total co-benefits are more uniform at 2-5 ppb with U.S. average of 3.55 ppb. Comparing the two mechanisms of co-benefits, we find that reductions of co-emitted air pollutants have a much greater influence on both PM2.5 (96% of the total co-benefits) and O3 (89% of the total) than the second co-benefits mechanism via slowing climate change, consistent with West et al. (2013). GHG mitigation from foreign countries contributes more to the U.S. O3 reduction (76% of the total) than that from domestic GHG mitigation only (24%), highlighting the importance of global methane reductions and the intercontinental transport of air pollutants. For PM2.5, the benefits of domestic GHG control are greater (74% of total). Since foreign contributions to co-benefits can be substantial, with foreign O3 benefits much larger than those from domestic reductions, previous studies that focus on local or regional co-benefits may greatly underestimate the total co-benefits of global GHG reductions. We conclude that the U.S. can gain significantly greater domestic air quality co-benefits by engaging with other nations to control GHGs.

Project description:Meteorology and long-term trends in air pollutant concentrations may obscure the results from short-term policies implemented to improve air quality. This study presents changes in CO, NO2, O3, SO2, PM10, and PM2.5 based on their anomalies during the COVID-19 partial (Phase 2) and total (Phase 3) lockdowns in Mexico City (MCMA). To minimise the impact of the air pollutant long-term trends, pollutant anomalies were calculated using as baseline truncated Fourier series, fitted with data from 2016 to 2019, and then compared with those from the lockdown. Additionally, days with stagnant conditions and heavy rain were excluded to reduce the impact of extreme weather changes. Satellite observations for NO2 and CO were used to contrast the ground-based derived results. During the lockdown Phase 2, only NO2 exhibited significant decreases (p < 0.05) of between 10 and 23% due to reductions in motor vehicle emissions. By contrast, O3 increased (p < 0.05) between 16 and 40% at the same sites where NO2 decreased. During Phase 3, significant decreases (p < 0.05) were observed for NO2 (43%), PM10 (20%), and PM2.5 (32%) in response to the total lockdown. Although O3 concentrations were lower in Phase 3 than during Phase 2, those did not decrease (p < 0.05) from the baseline at any site despite the total lockdown. SO2 decreased only during Phase 3 in a near-road environment. Satellite observations confirmed that NO2 decreased and CO stabilised during the total lockdown. Air pollutant changes during the lockdown could be overestimated between 2 and 10-fold without accounting for the influences of meteorology and long-term trends in pollutant concentrations. Air quality improved significantly during the lockdown driven by reduced NO2 and PM2.5 emissions despite increases in O3, resulting in health benefits for the MCMA population. A health assessment conducted suggested that around 588 deaths related to air pollution exposure were averted during the lockdown. Our results show that to reduce O3 within the MCMA, policies must focus on reducing VOCs emissions from non-mobile sources. The measures implemented during the COVID-19 lockdowns provide valuable information to reduce air pollution through a range of abatement strategies for emissions other than from motor vehicles.

Project description:ImportanceReducing exposure to fine particulate matter (<2.5 μm [PM2.5]) air pollution improves cardiopulmonary morbidity and mortality. However, the public health relevance of air quality index (AQI) activity guidelines under present-day environmental conditions in the US has not been critically assessed.ObjectiveTo evaluate the public health relevance of following PM2.5 AQI activity guidance in preventing serious atherosclerotic cardiovascular disease (ASCVD) and pulmonary events among adults in the US.Design, setting, and participantsThis cross-sectional modeling study involved the general adult population and sensitive individuals as designated by the US Environmental Protection Agency (EPA), including adults with preexisting ASCVD or lung disease (asthma or chronic obstructive pulmonary disease). The study was conducted between August 1, 2023, and January 31, 2024.ExposuresDaily AQI strata for PM2.5 and the corresponding activity recommendations.Main outcomes and measuresThe main outcome was the number needed to treat (NNT) per day by following activity guidance across daily AQI strata to prevent 1 serious ASCVD or pulmonary event among relevant populations. To calculate PM2.5-induced excess disease event rates per day, estimated baseline disease-specific daily event rates for each group were multiplied by the increase in risks due to PM2.5 levels at each AQI stratum. The number of events prevented per day was calculated by multiplying each excess disease event rate by the percentage in exposure reduction plausibly incurred by following population-specific activity guidance at each AQI level. The NNT is the reciprocal of the number of events prevented.ResultsThe NNT to prevent ASCVD events was high for the general population and for patients with ASCVD across all AQI strata. The range of values was comparatively lower to prevent pulmonary events among adults with lung disease. During most days (96%) when activity recommendations were promulgated due to elevated PM2.5 (AQI, 101-200), the NNT to prevent a serious disease event remained very high for the general population (>18 million), patients with ASCVD (approximately 1.6-5 million), and adults with lung disease (approximately 66 000-202 000).Conclusions and relevanceThese findings suggest that existing PM2.5 AQI activity recommendations are of questionable public health relevance in present-day conditions and merit consideration for updating to improve their potential effectiveness.

Dataset Information

Integrating Air Quality and Public Health Benefits in U.S. Decarbonization Strategies.

Publications

Integrating Air Quality and Public Health Benefits in U.S. Decarbonization Strategies.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets